BETHESDA, Md. - Researchers at the National Institutes of Health say they have identified a potential new antiviral drug that could help treat COVID-19.
The drug, TEMPOL, is a promising oral antiviral drug which researchers say limit SARS-CoV-2, the disease that causes COVID-19, by impairing the disease’s viral enzyme otherwise known as RNA replicate.
RNA replicase is the enzyme that allows the virus to replicate its genetic material and make copies of itself once it has infected a host cell."We urgently need additional effective, accessible treatments for COVID-19," said Diana W.